3-Amino-7-azaindazole - CAS 6752-16-5
Catalog: |
BB033315 |
Product Name: |
3-Amino-7-azaindazole |
CAS: |
6752-16-5 |
Synonyms: |
2H-pyrazolo[3,4-b]pyridin-3-amine |
IUPAC Name: | 2H-pyrazolo[3,4-b]pyridin-3-amine |
Description: | 3-Amino-7-azaindazole (CAS# 6752-16-5) is a compound useful in organic synthesis. |
Molecular Weight: | 134.14 |
Molecular Formula: | C6H6N4 |
Canonical SMILES: | C1=CC2=C(NN=C2N=C1)N |
InChI: | InChI=1S/C6H6N4/c7-5-4-2-1-3-8-6(4)10-9-5/h1-3H,(H3,7,8,9,10) |
InChI Key: | LUAQTQAFUORQHV-UHFFFAOYSA-N |
Boiling Point: | 406.7 °C at 760 mmHg |
Purity: | 97.0 % |
Density: | 1.48 g/cm3 |
MDL: | MFCD04113611 |
LogP: | 1.12130 |
GHS Hazard Statement: | H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P310, P321, P330, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021005183-A1 | Inhibitor of map kinase interacting serine/threonine kinase 1 (mnk1) and map kinase interacting serine/threonine kinase 2 (mnk2), cancer therapy and therapeutic combinations | 20190710 |
CN-109503488-A | 2- substituent methyl -4- substituted-amino methylphenol analog derivative and its medical usage | 20181214 |
TW-202024071-A | Pyrazolo[3,4-b]pyridine compounds as inhibitors of tam and met kinases | 20180830 |
AU-2019264078-A1 | Novel heterocycle derivative | 20180502 |
CN-107501306-B | Nine core zinc multifunctional crystal materials of one kind and preparation method thereof | 20170911 |
PMID | Publication Date | Title | Journal |
21699136 | 20110728 | Selectivity of kinase inhibitor fragments | Journal of medicinal chemistry |
12230249 | 20020501 | Synthesis and antiproliferative activity in vitro of new 3-substituted aminopyrazolo[3,4-b]pyridines | Acta poloniae pharmaceutica |
11512271 | 20010701 | Synthesis and antiproliferative activity in vitro of new derivatives of 3-aminopyrazolo[3,4-b]pyridine. Part 1. Reaction of 3-aminopyrazolo[3,4-b]pyridine with 1,3-, 1,4-diketones and alpha,beta-unsaturated ketones | Archiv der Pharmazie |
Complexity: | 127 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 134.059246208 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 134.059246208 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 67.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Azaindazole
-
[1256833-42-7]
5-Fluoro-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile
-
[937598-58-8]
1-(4-Fluorophenyl)-3,6-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carbohydrazide
-
[886503-31-7]
1,3-Dimethyl-6-(3-nitrophenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
-
[937598-72-6]
1,3-Dimethyl-6-(4-methylphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
-
[938018-19-0]
1,3-Dimethyl-6-(p-tolyl)-1H-pyrazolo[3,4-b]pyridine-4-carbohydrazide
-
[80537-07-1]
2-Phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid
Indazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS